Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126032991 | 12603299 | 1 | I | 20160715 | 20160728 | 20160728 | EXP | JP-ACTAVIS-2016-16275 | ACTAVIS | YAMASHINA T, TAKADA R, UEDO N, AKASAKA T, HANAOKA N, TAKEUCHI Y ET AL. PROSPECTIVE SMALL BOWEL MUCOSAL ASSESSMENT IMMEDIATELY AFTER CHEMORADIOTHERAPY OF UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER USING CAPSULE ENDOSCOPY: A CASE SERIES. ANN GASTROENTEROL. 2016;29(3):386-8. | 0.00 | A | M | Y | 0.00000 | 20160728 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126032991 | 12603299 | 1 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | 1000 MG/M2, CYCLICAL; WEEKLY | U | UNCONFIRMED | 79160 | 1000 | MG/M**2 | UNK |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126032991 | 12603299 | 1 | Pancreatic carcinoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126032991 | 12603299 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126032991 | 12603299 | Decreased appetite | |
126032991 | 12603299 | Duodenitis | |
126032991 | 12603299 | Enteritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |